Literature DB >> 23681278

[Nutritional therapy in acute pancreatitis].

J Ockenga1.   

Abstract

Acute pancreatitis is a frequent clinical entity in the West. About 80% of patients with acute pancreatitis develop edematous pancreatitis, while 20% develop necrotizing pancreatitis: The latter is a potentially life-threatening disease. In this case, early enteral nutrition has been shown to improve the course of the disease. Usually, gastric enteral nutrition with a polymeric formula via a nasogastric tube is possible; only in a minority of patients is jejunal feeding necessary owing to the high gastric residual volume. An elemental formula is useful for patients with significant intestinal maldigestion. If enteral feeding is not feasible within 5-7 days, (additional) parenteral nutrition has to be considered. Individualized--primary enteral--nutritional support is an essential part of a multimodal therapy in severe acute pancreatitis and it improves clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23681278     DOI: 10.1007/s00063-012-0202-2

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  32 in total

1.  Role of individually staged nutritional support in the management of severe acute pancreatitis.

Authors:  Bei Sun; Yue Gao; Jun Xu; Xiao-Lin Zhou; Zun-Qiang Zhou; Chang Liu; Hong-Chi Jiang
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2004-08

2.  Early total parenteral nutrition in acute pancreatitis: lack of beneficial effects.

Authors:  H C Sax; B W Warner; M A Talamini; F N Hamilton; R H Bell; J E Fischer; R H Bower
Journal:  Am J Surg       Date:  1987-01       Impact factor: 2.565

3.  ESPEN Guidelines on Enteral Nutrition: Intensive care.

Authors:  K G Kreymann; M M Berger; N E P Deutz; M Hiesmayr; P Jolliet; G Kazandjiev; G Nitenberg; G van den Berghe; J Wernerman; C Ebner; W Hartl; C Heymann; C Spies
Journal:  Clin Nutr       Date:  2006-05-11       Impact factor: 7.324

4.  Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis.

Authors:  Ajith K Siriwardena; James M Mason; Srinivasan Balachandra; Anil Bagul; Simon Galloway; Laura Formela; Jonathan G Hardman; Saurabh Jamdar
Journal:  Gut       Date:  2007-03-13       Impact factor: 23.059

5.  Acute pancreatitis in five European countries: etiology and mortality.

Authors:  Lucio Gullo; Marina Migliori; Attila Oláh; Gyula Farkas; Philippe Levy; Constantine Arvanitakis; Paul Lankisch; Hans Beger
Journal:  Pancreas       Date:  2002-04       Impact factor: 3.327

Review 6.  Systematic review: nutritional support in acute pancreatitis.

Authors:  M S Petrov; R D Pylypchuk; N V Emelyanov
Journal:  Aliment Pharmacol Ther       Date:  2008-09-15       Impact factor: 8.171

7.  Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial.

Authors:  Marc Gh Besselink; Hjalmar C van Santvoort; Erik Buskens; Marja A Boermeester; Harry van Goor; Harro M Timmerman; Vincent B Nieuwenhuijs; Thomas L Bollen; Bert van Ramshorst; Ben Jm Witteman; Camiel Rosman; Rutger J Ploeg; Menno A Brink; Alexander Fm Schaapherder; Cornelis Hc Dejong; Peter J Wahab; Cees Jhm van Laarhoven; Erwin van der Harst; Casper Hj van Eijck; Miguel A Cuesta; Louis Ma Akkermans; Hein G Gooszen
Journal:  Lancet       Date:  2008-02-14       Impact factor: 79.321

Review 8.  Enteral versus parenteral nutrition for acute pancreatitis.

Authors:  Mohammed Al-Omran; Zaina H Albalawi; Mariam F Tashkandi; Lubna A Al-Ansary
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

9.  Evidence for early oxidative stress in acute pancreatitis. Clues for correction.

Authors:  J M Braganza; P Scott; D Bilton; D Schofield; C Chaloner; N Shiel; L P Hunt; T Bottiglieri
Journal:  Int J Pancreatol       Date:  1995-02

Review 10.  Acute pancreatitis.

Authors:  Jean-Louis Frossard; Michael L Steer; Catherine M Pastor
Journal:  Lancet       Date:  2008-01-12       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.